BioSpace News Archive

Veracyte Announces Multiple Studies to Be Presented at ATA Annual Meeting Demonstrating “Real World” Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis

Nutriband Inc. (OTCQB: NTRB), is pleased to announce it has signed the definitive acquisition agreement to acquire Carmel Biosciences, Inc. The acquisition is expected to be valued at approximately $2,700,000 and will be paid in company stock in the amount of 350,000 restricted common shares.

U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, will be featured alongside other top doctors in the upcoming webinar summit, the Fix for Female Hormones.

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (“MYM”) is pleased to announce that it has entered into an agreement with Amsterdam-based Dutch Passion Seed Company for the production and distribution of Dutch Passion branded products and seed genetics in Canada.

Aridis Pharmaceuticals, Inc., (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections, today announced that Fred Kurland, J.D., MBA, Chief Financial Officer, and Wolfgang Dummer, M.D., Ph.D., Chief Medical Officer, will present a corporate overview and strategies for growth at the 2018 Cantor Global Healthcare Conference

Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease, today announced that updated data on its lead compound, bryostatin, will be presented during the 11th Edition of Clinical Trials on Alzheimer’s Disease to be held in Barcelona, Spain from October 24th - 27th, 2018.

ClearLight Diagnostics announces the appointment of Laurie Goodman, Ph.D. as Chief Executive Officer (CEO).

Cerus’ president and chief executive officer will present and provide a corporate update at the Cantor Fitzgerald 2018 Global Healthcare Conference in New York City on Tuesday, October 2, 2018 at 3:25 p.m. ET.

Contract Development and Manufacturing Organization successfully realizes a new creative format

Woodworth is an accomplished architect with more than 20 years of experience that builds on her earlier career as a nurse and her ongoing work as an educator.